Literature DB >> 25586825

The MAST® D68C test: an interesting tool for detecting extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.

C Nourrisson1, R N Tan, C Hennequin, L Gibold, R Bonnet, F Robin.   

Abstract

The Mast® D68C test is a phenotypical test that allows the detection of extended-spectrum β-lactamase (ESBL) production, even in AmpC-producing Enterobacteriaceae. We assessed its detection accuracy against a large collection of 106 Enterobacteriaceae isolates producing a wide diversity of well-characterized β-lactamases (53 ESBL producers, 25 Amp. producers, seven AmpC and ESBL producers, five carbapenemase producers, three carbapenemase and ESBL producers, one AmpC, carbapenemase, and ESBL producer, three TEM-1 producers, three SHV-1 producers, three OXA-1 producers, and one hyperOXY producer, ATCC 35218, ATCC 25922 [a β-lactamase-negative control strain]). The results were compared with those of the double disk test and the Clinical and Laboratory Standards Institute (CLSI) confirmatory test for the detection of ESBL. The sensitivity was 90.6 % for the synergy test, 87.5 % for the CLSI method, and only 73.1 % for D68C, which, however, reached 92.1 % if the strains for which supplementary investigations were recommended and the complex mutant TEM (CMT)-producing strains were excluded versus 94.1 % and 88.2 % for the other methods. The specificity was 90.2 % for the synergy test and 100 % for the CLSI method and D68C. D68C was also efficient in detecting AmpC-overproducing strains (sensitivity = 97 %, specificity = 95.9 %): among the 74 strains belonging to natural AmpC-producing species, the sensitivity and specificity were 100 and 94.8 %, respectively. The Mast® D68C-test is a promising method that is easy to perform for the detection of current ESBLs and could also be useful for the detection of plasmid-encoded AmpC enzymes (sensitivity = 100 %).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25586825     DOI: 10.1007/s10096-014-2305-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae.

Authors:  Silke Polsfuss; Guido V Bloemberg; Jacqueline Giger; Vera Meyer; Erik C Böttger; Michael Hombach
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

3.  Evaluation of the Vitek-2 extended-spectrum beta-lactamase test against non-duplicate strains of Enterobacteriaceae producing a broad diversity of well-characterised beta-lactamases.

Authors:  F Robin; J Delmas; C Schweitzer; R Bonnet
Journal:  Clin Microbiol Infect       Date:  2007-12-10       Impact factor: 8.067

4.  Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain.

Authors:  E Miró; J Agüero; M N Larrosa; A Fernández; M C Conejo; G Bou; J J González-López; N Lara; L Martínez-Martínez; A Oliver; B Aracil; J Oteo; A Pascual; J Rodríguez-Baño; L Zamorano; F Navarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-07       Impact factor: 3.267

5.  False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins.

Authors:  Alejandro Beceiro; Sunil Maharjan; Tom Gaulton; Michel Doumith; Nelson C Soares; Hiran Dhanji; Marina Warner; Maeve Doyle; Mary Hickey; Gordon Downie; Germán Bou; David M Livermore; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2011-07-08       Impact factor: 5.790

6.  Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis.

Authors:  S Peter-Getzlaff; S Polsfuss; M Poledica; M Hombach; J Giger; E C Böttger; R Zbinden; G V Bloemberg
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

7.  Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase.

Authors:  D Sirot; J Sirot; R Labia; A Morand; P Courvalin; A Darfeuille-Michaud; R Perroux; R Cluzel
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

8.  Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum beta-lactamase VEB-1 in Pseudomonas aeruginosa.

Authors:  T Naas; L Poirel; A Karim; P Nordmann
Journal:  FEMS Microbiol Lett       Date:  1999-07-15       Impact factor: 2.742

Review 9.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 10.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

View more
  7 in total

Review 1.  Plasmids carrying DHA-1 β-lactamases.

Authors:  Claire Hennequin; Viviane Ravet; Frédéric Robin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-17       Impact factor: 3.267

2.  Rapid Detection of Extended-Spectrum β-Lactamases (ESBL) and AmpC β-Lactamases in Enterobacterales: Development of a Screening Panel Using the MALDI-TOF MS-Based Direct-on-Target Microdroplet Growth Assay.

Authors:  Carlos L Correa-Martínez; Evgeny A Idelevich; Katrin Sparbier; Markus Kostrzewa; Karsten Becker
Journal:  Front Microbiol       Date:  2019-01-24       Impact factor: 5.640

3.  Virulence characterization of Klebsiella pneumoniae and its relation with ESBL and AmpC beta-lactamase associated resistance.

Authors:  Elghar Soltani; Alka Hasani; Mohammad Ahangarzadeh Rezaee; Tahereh Pirzadeh; Mahin Ahangar Oskouee; Akbar Hasani; Arezoo Noie Oskouie; Ehsan Binesh
Journal:  Iran J Microbiol       Date:  2020-04

4.  High β-lactam resistance in Gram-negative bacteria associated with kennel cough and cat flu in Egypt.

Authors:  Hazim O Khalifa; Atef F Oreiby; Takashi Okanda; Yasuyuki Kato; Tetsuya Matsumoto
Journal:  Sci Rep       Date:  2021-02-08       Impact factor: 4.996

Review 5.  Escherichia coli β-Lactamases: What Really Matters.

Authors:  Priyanka Bajaj; Nambram S Singh; Jugsharan S Virdi
Journal:  Front Microbiol       Date:  2016-03-30       Impact factor: 5.640

6.  Decline in AmpC β-lactamase-producing Escherichia coli in a Dutch teaching hospital (2013-2016).

Authors:  Evert den Drijver; Jaco J Verweij; Carlo Verhulst; Stijn Oome; Joke Soer; Ina Willemsen; Eefje J A Schrauwen; Marjolein F Q Kluytmans-van den Bergh; Jan A J W Kluytmans
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

7.  Development of an algorithm to discriminate between plasmid- and chromosomal-mediated AmpC β-lactamase production in Escherichia coli by elaborate phenotypic and genotypic characterization.

Authors:  Jordy P M Coolen; Evert P M den Drijver; Jan A J W Kluytmans; Jaco J Verweij; Bram A Lamberts; Joke A C J Soer; Carlo Verhulst; Heiman F L Wertheim; Eva Kolwijck
Journal:  J Antimicrob Chemother       Date:  2019-12-01       Impact factor: 5.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.